Clinical Trials in Tennessee

Showing 5141-5160 of 20,239 trials

Real-World Evidence on the Cardiovascular Safety of CONTRAVE® in the United States (U.S.)

NCT06090461

The fixed-dose combination of naltrexone 8mg and bupropion 90mg extended-release oral tablet is marketed under the trade name CONTRAVE® in the U.S. In this protocol, the investigators propose to generate real-world evidence (RWE) from electronic health records (EHR) and linked claims data to assess the cardiovascular safety of CONTRAVE® and all combined use of naltrexone and bupropion (NB) in usual clinical practice.

Obesity

Currax Pharmaceuticals31,889 participantsStarted Sep 2014

Brentwood, Tennessee, United States

RECRUITINGPhase 129 miles

DCSZ11 as a Monotherapy and in Combination in Patients With Advanced or Metastatic Solid Tumors

NCT05785754

This is a multicenter, open-label, Phase 1 study to assess the effects of DCSZ11 as a monotherapy and in combination in patients with advanced or metastatic solid tumors. The study consists of an Escalation Phase (Phase 1a) and a Dose Expansion/Optimization Phase (Phase 1b).

Advanced or Metastatic Solid Tumors

DynamiCure Biotechnology320 participantsStarted Jun 2023

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Scottsdale, Arizona, United States +32 more locations

Real-World Evidence on the Cardiovascular Safety of CONTRAVE® in the United States (U.S.)

DCSZ11 as a Monotherapy and in Combination in Patients With Advanced or Metastatic Solid Tumors

Find Trials by Condition in Tennessee

Effect of Ketamine and Etomidate During RSI on Long Term Outcomes

Use of Accelerometer for Quantification of Neurogenic Orthostatic Hypotension Symptoms

Paclitaxel Coated Balloon for the Treatment of Chronic bEnigN sTricture- Bowel

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Clinical Activity of GSK5733584 for Injection in Participants With Advanced Solid Tumors

A Study Evaluating Efficacy and Safety of VX-993 for Acute Pain After a Bunionectomy

Optimizing the Use of Ketamine to Reduce Chronic Postsurgical Pain

Efficacy, Safety, and PK of LX9211 in Participants With Diabetic Peripheral Neuropathic Pain

Open Label Extension for 43USSA1812

A Study of DS-8201a in Metastatic Breast Cancer Previously Treated With Trastuzumab Emtansine (T-DM1)

Post-Approval Study of the TREO Abdominal Stent-Graft System

COVID Protection After Transplant - Sanofi GSK (CPAT-SG) Study

A Study for Participants Previously Treated With Century Therapeutics Cellular Therapy Product

Precision Ventilation vs Standard Care for Acute Respiratory Distress Syndrome

Study of V117957 in Overactive Bladder Syndrome

Registry of Arthrex Hand and Wrist Products

A Phase 1, Open-Label Study of Teprotumumab in Patients With Diabetic Macular Edema (DME)

A First-in-human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of DS-6051b

Implementing Precision Medicine in cOmmunity HospiTALs